The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Sunday newspaper round-up: Delta mutation, Foreign summer holidays, Anglo American

Sun, 06th Jun 2021 12:20

(Sharecast News) - The decision to reopen on June 21 has been made "more difficult" by the Indian variant's spread to the most dominant variant in the UK, the Health Secretary has said. Matt Hancock told Sky News that the latest advice the Government has received is that the so-called Delta mutation first identified in India is 40 per cent more transmissible than the previously dominant Kent variant. - Sunday Telegraph
With foreign summer holiday plans in disarray following weeks of uncertainty over popular European destinations, more tourists are scrapping plans for this year - and saving up for a bigger trip in 2022. "We have seen a surge in bookings for safaris to Kenya and Tanzania in 2022," says Liddy Pleasants from adventure travel agency Stubborn Mule. "Not only that but real bonanza-style North America road trips lasting two or three weeks. People have saved their holiday money for two years and they are determined to do something memorable." - Guardian

Mining colossus Anglo American has been accused of "greenwashing" by the secretive research outfit Boatman Capital, which claims that a group of South African coal mines it will spin off this week are "worthless". In its largest attack since targeting UK defence contractor Babcock nearly three years ago, Boatman alleges Thungela Resources' clean-up costs could be three times greater than the amounts disclosed to investors. - Sunday Telegraph

Grant Shapps has intervened to prevent a Mayfair hedge fund manager from cashing in on take off and landing slots at Heathrow owned by Flybe worth tens of millions of pounds. The Transport Secretary supported a decision by the Civil Aviation Authority to revoke Flybe's operating licence on Thursday. Had the decision not been rubber-stamped, Lucien Farrell of Cyrus Capital would have been free to transfer slots at Heathrow airport to a new ­company hoping to resurrect the Flybe brand after June 3. - Sunday Telegraph

The boss of Klarna has warned the Swedish buy now, pay later giant is likely to pick the US for its stock market listing, dealing a blow to Rishi Sunak's efforts to turn London into a fintech hub. "It's more likely that Klarna will list in the US," said Sebastian Siemiatkowski, Klarna's co-founder and chief executive. "The majority of my investors would say that's where you usually list [...] but are we going to consider London? And are there elements of how you guys are thinking about changing the rules that could make it more attractive? Absolutely." - Sunday Times

Britain's two national pharma champions are locked in a legal battle over royalties from a top-selling cancer drug. Astra Zeneca has launched a court claim against Glaxo Smith Kline, saying it should have a greater share of sales from its rival's drug, Zejula, a treatment for ovarian and other forms of cancer. A source suggested the claim's value could reach hundreds of millions of pounds. - Sunday Times

Bankers based in London are digging in their heels at being asked to relocate to other European hubs after Brexit. Staff at some of the City's largest companies are quitting their jobs rather than move abroad, as alternatives including Frankfurt, Paris and Amsterdam are proving less than alluring. - Financial Mail on Sunday

Sir Martin Sorrell has signalled a major summer surge for Britain's economy by declaring that the advertising market is the strongest he has seen it in his 45 years in business. The marketing guru predicted the 'ridiculous' growth in advertising spending by companies - seen as a key bellwether for the wider economy - may well continue for the rest of the year and into 2022. - Financial Mail on Sunday

One of Britain's top restaurant bosses has warned Ministers of a 'Doomsday scenario' for hospitality businesses unless all major Covid restrictions are removed as planned on June 21. Jeremy King, whose London empire includes the celebrity haunts The Wolseley and The Delaunay, said many restaurants would 'throw in the towel' without good news on a series of key Covid-19 rules. The Government is facing a 'perfect storm' of crucial decisions this week, he said. - Financial Mail on Sunday

More News
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.